¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, Àü¸Á ¹× ¿¹Ãø(2024-2031³â)
Global Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1529163
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 295 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,208,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,250,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,750,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 6.9%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 71¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ÀÇ·á±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î PAD Ä¡·áÀÇ »óȲÀÌ Å©°Ô ¹Ù²î¸é¼­ »õ·Î¿î Èñ¸ÁÀÌ »ý°Ü³µ°í, ȯÀÚµéÀÇ Ä¡·á °á°úµµ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú ¿ª½Ã ±â¼ú ¹ßÀüÀÌ Å« ¿µÇâÀ» ¹ÌÄ¡´Â ºÐ¾ßÀÔ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ¾à¹° ¿ëÃâ ½ºÅÙÆ®, Á×Á¾ ÀýÁ¦¼ú¿ë ÀåÄ¡, ÃÖ¼Òħ½À ¼ö¼úÀº È¿°ú°¡ ³ôÁö¸¸, ¸¹Àº ȯÀڵ鿡°Ô °í°¡À̱⠶§¹®¿¡ Á¢±ÙÇϱ⠾î·Á¿î °æ¿ì°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í±Þ PAD Ä¡·á¿¡ µû¸¥ ³ôÀº ºñ¿ëÀº Çõ½Å°ú ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ °í±Þ PAD Ä¡·áÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀå¿¡ Å« À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, COVID-19·Î ÀÎÇÑ °æÁ¦ ħüµµ Å« ¹®Á¦¸¦ ¾ß±âÇß½À´Ï´Ù. ¸¹Àº »ç¶÷µéÀÌ ½Ç¾÷°ú ¼Òµæ °¨¼Ò·Î ÀÎÇØ °æÁ¦Àû ¾î·Á¿ò¿¡ Á÷¸éÇÏ¿© ÀÇ·áºñ¸¦ ¸¶·ÃÇÒ ¼ö ¾ø°Ô µÇ¾ú½À´Ï´Ù. ÀÌ¹Ì ¸¹Àº PAD ȯÀڵ鿡°Ô À庮ÀÌ µÇ¾ú´ø ³ôÀº Ä¡·áºñ´Â ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ´õ Å« ºÎ´ãÀ» ¾È°ÜÁÖ¾ú½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀڵ鵵 ÆÒµ¥¹Í ±â°£ µ¿¾È Å« ¾î·Á¿ò¿¡ Á÷¸éÇß½À´Ï´Ù. ÀÌó·³ ÆÒµ¥¹ÍÀº ½ÃÀå Àü¹Ý¿¡ °ÉÃÄ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

Á¦Ç° À¯Çü Àü¸Á

Á¦Ç° À¯Çü¿¡ µû¶ó ½ÃÀåÀº ÀåÄ¡¿Í ÀǾàǰÀ¸·Î ³ª´¹´Ï´Ù. ±â±â ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 41%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¾à¹° Ä¡·á¸¸À¸·Î´Â ÃæºÐÇÏÁö ¾ÊÀº ÁøÇ༺ ÁúȯÀÇ °æ¿ì, ÀÇ·á±â±â´Â PADÀÇ Áø´Ü, °³ÀÔ ¹× °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀåÄ¡ ºÎ¹®¿¡´Â Áø´Ü¿ë ¿µ»ó µµ±¸, Ç÷°ü¼ºÇü¼ú¿ë dz¼±, ½ºÅÙÆ®, Á×Á¾ÀýÁ¦¼ú¿ë ÀåÄ¡ µî ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ.

ÃÖÁ¾»ç¿ëÀÚ Àü¸Á

ÃÖÁ¾»ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î ½ÃÀåÀº Àü¹® Ŭ¸®´Ð°ú º´¿øÀ¸·Î ºÐ·ùµË´Ï´Ù. Àü¹® Ŭ¸®´Ð ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 45%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. Àü¹® Ŭ¸®´ÐÀº ȯÀÚ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀ¸·Î À¯¸íÇÏ¸ç °³ÀÎÈ­ µÈ Ä¡·á °èȹ°úº¸´Ù ¸é¹ÐÇÑ È¯ÀÚ ¸ð´ÏÅ͸µÀ» Á¦°øÇÕ´Ï´Ù. °Ç°­ °á°úÀÇ °³¼±Àº °³ÀÎÈ­µÈ Ä¡·á¿¡ ÁßÁ¡À» µÐ °á°úÀ̸ç, ȯÀÚ ¸¸Á·µµ¿Í Ä¡·á ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ È¯ÀÚ ¼øÀÀµµµµ Çâ»óµË´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î º¸¸é ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA¿¡ °ÉÃÄ ºÐ¼®µÇ¾ú½À´Ï´Ù. ºÏ¹Ì ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 39%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Áö¿ª¿¡´Â ´ç´¢º´, °íÇ÷¾Ð, ºñ¸¸, Èí¿¬°ú °°Àº PAD À§Çè ¿ä¼ÒÀÇ ³ôÀº À¯º´·ü°ú °°Àº ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÌ·¯ÇÑ ¿ìÀ§¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦5Àå ¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦6Àå ¼¼°èÀÇ ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀå : Áö¿ªº°

Á¦7Àå ±â¾÷ °³¿ä

Á¦8Àå ¸»Ãʵ¿¸ÆÁúȯ ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Peripheral Artery Disease Market size is expected to reach $7.1 billion by 2031, rising at a market growth of 6.9% CAGR during the forecast period.

Europe has a high prevalence of PAD risk factors, including an aging population, high rates of smoking, and increasing incidence of diabetes and hypertension. Europe's strong healthcare systems, particularly in countries like Germany, France, and the United Kingdom, contribute to the region's significant market share. Consequently, the European region would acquire nearly 30% of the total market share by 2031.

Parotid artery disease is a common cardiovascular disorder that frequently results in mobility challenges and discomfort. High blood pressure, or hypertension, is an additional significant risk factor for PAD. According to the World Health Organization (WHO), hypertension affects approximately 1.28 billion adults aged 30-79 years everywhere in the world. Hence, as the prevalence of PAD continues to rise, the demand for effective treatments and management strategies will drive market growth.

Additionally, the rapid advancements in medical technology are significantly transforming the landscape of PAD treatment, offering new hope and improved patient outcomes. Minimally invasive procedures are another area where technological advancements have profoundly impacted. Thus, such advancements are driving the growth of the market.

However, Drug-eluting stents, atherectomy devices, and minimally invasive procedures, while highly effective, come with substantial price tags that can be prohibitive for many patients. Furthermore, the high costs associated with advanced PAD treatments can stifle innovation and market growth. Hence, the high cost of advanced PAD treatments is a significant barrier to market growth.

Moreover, the economic downturn of the pandemic also posed significant challenges. Many individuals faced financial hardships due to job losses and reduced incomes, affecting their ability to afford medical care. High treatment costs, already a barrier for many PAD patients, became even more prohibitive during the pandemic. Healthcare providers also faced significant challenges during the pandemic. Thus, the pandemic had an overall negative impact on the market.

Product Type Outlook

Based on product type, the market is bifurcated into devices and drugs. The devices segment procured 41% revenue share in the market in 2023. In advanced cases where pharmaceutical treatments alone are insufficient, medical devices are essential for the diagnosis, intervention, and management of PAD. The devices segment includes various products such as diagnostic imaging tools, angioplasty balloons, stents, and atherectomy devices.

End User Outlook

On the basis of end user, the market is classified into specialty clinics and hospitals. The specialty clinics segment witnessed 45% revenue share in the market in 2023. Specialty clinics are known for their patient-centered approach, providing personalized care plans and closer patient monitoring. Improved health outcomes are the result of this emphasis on individualized treatment, which also increases patient satisfaction and patient adherence to treatment protocols.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 39% revenue share in the market in 2023. There are numerous factors that contribute to this dominance, including the high prevalence of PAD risk factors in the region, including diabetes, hypertension, obesity, and smoking.

List of Key Companies Profiled

Global Peripheral Artery Disease Market Report Segmentation

By Product Type

By End User

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Peripheral Artery Disease Market by Product Type

Chapter 5. Global Peripheral Artery Disease Market by End User

Chapter 6. Global Peripheral Artery Disease Market by Region

Chapter 7. Company Profiles

Chapter 8. Winning Imperatives for Peripheral Artery Disease Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â